Pacific Radiance Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Pacific Radiance.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Energy Services earnings growth | 15.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Pacific Radiance Ltd. (SGX:RXS) Stock's 31% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jun 03Pacific Radiance's (SGX:RXS) Weak Earnings Might Be Worse Than They Appear
Apr 22Even With A 30% Surge, Cautious Investors Are Not Rewarding Pacific Radiance Ltd.'s (SGX:RXS) Performance Completely
Mar 11Investors Don't See Light At End Of Pacific Radiance Ltd.'s (SGX:RXS) Tunnel And Push Stock Down 27%
Nov 27Why Pacific Radiance's (SGX:RXS) Healthy Earnings Aren’t As Good As They Seem
Nov 21In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pacific Radiance has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2023 | 31 | 15 | 4 | 9 | N/A |
9/30/2023 | 32 | 4 | 5 | 6 | N/A |
6/30/2023 | 31 | 307 | 11 | 11 | N/A |
3/31/2023 | 34 | 307 | 11 | 11 | N/A |
12/31/2022 | 30 | 325 | 1 | 2 | N/A |
9/30/2022 | 24 | 324 | 4 | 4 | N/A |
6/30/2022 | 19 | 16 | -4 | -4 | N/A |
3/31/2022 | 12 | 12 | 0 | -1 | N/A |
12/31/2021 | 10 | 1 | 6 | 6 | N/A |
9/30/2021 | -33 | 16 | 11 | 10 | N/A |
6/30/2021 | -18 | 6 | 7 | 8 | N/A |
3/31/2021 | -5 | 1 | 8 | 9 | N/A |
12/31/2020 | 9 | -6 | 6 | 7 | N/A |
9/30/2020 | 71 | -76 | 6 | 6 | N/A |
6/30/2020 | 71 | -75 | 11 | 11 | N/A |
3/31/2020 | 76 | -78 | 7 | 8 | N/A |
12/31/2019 | 75 | -85 | -1 | 0 | N/A |
9/30/2019 | 69 | -103 | -6 | -2 | N/A |
6/30/2019 | 69 | -96 | -12 | -9 | N/A |
3/31/2019 | 65 | -91 | -11 | -9 | N/A |
12/31/2018 | 61 | -99 | -10 | -9 | N/A |
9/30/2018 | 65 | -320 | -12 | -10 | N/A |
6/30/2018 | 64 | -329 | -9 | -8 | N/A |
3/31/2018 | 65 | -331 | -18 | -16 | N/A |
12/31/2017 | 68 | -333 | -25 | -23 | N/A |
9/30/2017 | 61 | -72 | N/A | -32 | N/A |
6/30/2017 | 63 | -77 | N/A | -42 | N/A |
3/31/2017 | 65 | -127 | N/A | -43 | N/A |
12/31/2016 | 69 | -119 | N/A | -45 | N/A |
9/30/2016 | 79 | -85 | N/A | -53 | N/A |
6/30/2016 | 94 | -65 | N/A | -35 | N/A |
3/31/2016 | 109 | -5 | N/A | -23 | N/A |
12/31/2015 | 122 | 4 | N/A | 19 | N/A |
9/30/2015 | 137 | 11 | N/A | 67 | N/A |
6/30/2015 | 148 | 23 | N/A | 68 | N/A |
3/31/2015 | 162 | 53 | N/A | 87 | N/A |
12/31/2014 | 172 | 68 | N/A | 62 | N/A |
9/30/2014 | 177 | 80 | N/A | 62 | N/A |
6/30/2014 | 182 | 77 | N/A | 34 | N/A |
3/31/2014 | 179 | 66 | N/A | 34 | N/A |
12/31/2013 | 169 | 57 | N/A | 29 | N/A |
9/30/2013 | 156 | 43 | N/A | 18 | N/A |
6/30/2013 | 145 | 51 | N/A | 29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if RXS's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if RXS's earnings are forecast to grow faster than the SG market
High Growth Earnings: Insufficient data to determine if RXS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if RXS's revenue is forecast to grow faster than the SG market.
High Growth Revenue: Insufficient data to determine if RXS's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if RXS's Return on Equity is forecast to be high in 3 years time